Inflammation during the life cycle of the atherosclerotic plaque
Open accessThe DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
Inflammation orchestrates each stage of the life cycle of atherosclerotic plaques. Indeed, inflammatory mediators likely link many traditional and emerging risk factors with atherogenesis. Atheroma initiation involves endothelial activation with recruitment of leucocytes to the arterial intima, where they interact with lipoproteins or their derivatives that have accumulated in this layer. The prolonged and usually clinically silent progression of atherosclerosis involves periods of smouldering inflammation, punctuated by episodes of acute activation that may arise from inflammatory mediators released from sites of extravascular injury or infection or from subclinical disruptions of the plaque. Smooth muscle cells and infiltrating leucocytes can proliferate but also undergo various forms of cell death that typically lead to formation of a lipid-rich ‘necrotic’ core within the evolving intimal lesion. Extracellular matrix synthesized by smooth muscle cells can form a fibrous cap that overlies the lesion’s core. Thus, during progression of atheroma, cells not only procreate but perish. Inflammatory mediators participate in both processes. The ultimate clinical complication of atherosclerotic plaques involves disruption that provokes thrombosis, either by fracture of the plaque’s fibrous cap or superficial erosion. The consequent clots can cause acute ischaemic syndromes if they embarrass perfusion. Incorporation of the thrombi can promote plaque healing and progressive intimal thickening that can aggravate stenosis and further limit downstream blood flow. Inflammatory mediators regulate many aspects of both plaque disruption and healing process. Thus, inflammatory processes contribute to all phases of the life cycle of atherosclerotic plaques, and represent ripe targets for mitigating the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Self-citationAge-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · cited 1×
“9/14/2021 Peter Libby, MD myeloid cells in the peripheral blood provides a new link between aging and atherosclerosis.[72] The genes mutated in this condition, denoted clonal hematopoiesis of indeterminate potential, are”
BackgroundEndothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Gimbrone, M. A., & García-Cardeña, G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306301 · Cited by 3,476
A Prospective Natural-History Study of Coronary Atherosclerosis
Stone, G. W., Maehara, A., Lansky, A. J., de Bruyne, B., Cristea, E., Mintz, G. S., Mehran, R., McPherson, J., Farhat, N., Marso, S. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1002358 · Cited by 3,276
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Efficacy and safety of low-dose colchicine after myocardial infarction
Tardif, J.-C., Kouz, S., Waters, D. D., Bertrand, O. F., Diaz, R., Maggioni, A. P., Pinto, F. J., Ibrahim, R., Gamra, H., Kiwan, G. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1912388 · Cited by 3,159
The changing landscape of atherosclerosis
Libby, P. (2021) · Nature · doi:10.1038/s41586-021-03392-8 · Cited by 2,873 · cited 1×
“Moreover, the autopsy studies that disclosed fracture of the fibrous cap as a cause of fatal myocardial infarction were conducted in a period before widespread use of effective preventive therapies such as statins.(86) Indeed, we have argued that human atherosclerosis is changing in the current era of increasingly eff…”
BackgroundSelf-citationClonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683 · cited 2×
“ber of lines of evidence link inflammatory mediators to the accelerated atherosclerosis associated with clonal haematopoiesis.(73,75,76) As plaques progress, they often develop calcification.”
BackgroundSelf-citationColchicine in Patients with Chronic Coronary Disease
Nidorf, S. M., Fiolet, A. T. L., Mosterd, A., Eikelboom, J. W., Schut, A., Opstal, T. S. J., The, S. H. K., Xu, X.-F., Ireland, M. A., Lenderink, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021372 · Cited by 2,299 · cited 1×
“studies that colchicine can reduce recurrent atherothrombotic events reinforces this opportunity.(120,121) Yet, finding the ‘sweet spot’ of limiting”
BackgroundThe Pathogenesis of Atherosclerosis: (First of Two Parts)
Ross, R., & Glomset, J. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608122950707 · Cited by 2,014
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885
Ylä-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L., & Steinberg, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114271 · Cited by 1,880
Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died Suddenly
Burke, A. P., Farb, A., Malcom, G. T., Liang, Y.-H., Smialek, J., & Virmani, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361802 · Cited by 1,745
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
The smooth muscle cell in culture
Chamley-Campbell, J., Campbell, G. R., & Ross, R. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.1.1 · Cited by 1,553
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536 · cited 1×
“ber of lines of evidence link inflammatory mediators to the accelerated atherosclerosis associated with clonal haematopoiesis.(73,75,76) As plaques progress, they often develop calcification.”
BackgroundDoolittle, R. F., Hunkapiller, M. W., Hood, L. E., Devare, S. G., Robbins, K. C., Aaronson, S. A., & Antoniades, H. N. (1983) · Science · doi:10.1126/science.6304883 · Cited by 1,536
Ross, R., & Glomset, J. A. (1973) · Science · doi:10.1126/science.180.4093.1332 · Cited by 1,501
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · cited 1×
“In addition to anti-inflammatory mediators, a class of wellcharacterized lipid mediators may promote resolution of inflammation distinct from an anti-inflammatory aspect.(57,58) This distinction has importance as anti-inflammatory mediators may interfere with host defences and augment susceptibility to infection and i…”
BackgroundThe pathogenesis of atherosclerosis
(1972) · American Heart Journal · doi:10.1016/0002-8703(72)90090-7 · Cited by 1,329
Farb, A., Burke, A. P., Tang, A. L., Liang, Y., Mannan, P., Smialek, J., & Virmani, R. (1996) · Circulation · doi:10.1161/01.cir.93.7.1354 · Cited by 1,276
Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
Libby, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1216063 · Cited by 1,262
Self-citationSenescent intimal foam cells are deleterious at all stages of atherosclerosis
Childs, B. G., Baker, D. J., Wijshake, T., Conover, C. A., Campisi, J., & van Deursen, J. M. (2016) · Science · doi:10.1126/science.aaf6659 · Cited by 1,195
Nicholls, S. J., Puri, R., Anderson, T., Ballantyne, C. M., Cho, L., Kastelein, J. J. P., Koenig, W., Somaratne, R., Kassahun, H., Yang, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.16951 · Cited by 1,178
The Pathogenesis of Atherosclerosis: (Second of Two Parts)
Ross, R., & Glomset, J. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608192950805 · Cited by 1,163
Natural regulatory T cells control the development of atherosclerosis in mice
Ait-Oufella, H., Salomon, B. L., Potteaux, S., Robertson, A.-K. L., Gourdy, P., Zoll, J., Merval, R., Esposito, B., Cohen, J. L., Fisson, S., et al. (2006) · Nature Medicine · doi:10.1038/nm1343 · Cited by 1,100
Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure
Swirski, F. K., & Nahrendorf, M. (2013) · Science · doi:10.1126/science.1230719 · Cited by 1,086
Myocardial infarction accelerates atherosclerosis
Dutta, P., Courties, G., Wei, Y., Leuschner, F., Gorbatov, R., Robbins, C. S., Iwamoto, Y., Thompson, B., Carlson, A. L., Heidt, T., et al. (2012) · Nature · doi:10.1038/nature11260 · Cited by 1,079
Self-citationLocal proliferation dominates lesional macrophage accumulation in atherosclerosis
Robbins, C. S., Hilgendorf, I., Weber, G. F., Theurl, I., Iwamoto, Y., Figueiredo, J.-L., Gorbatov, R., Sukhova, G. K., Gerhardt, L. M. S., Smyth, D., et al. (2013) · Nature Medicine · doi:10.1038/nm.3258 · Cited by 1,041 · cited 1×
“initial phases of atherogenesis while local proliferation typifies the established atherosclerotic plaque.(39) Knowledge of leucocyte kinetics in hu-”
BackgroundSelf-citationTargeting inflammation in atherosclerosis — from experimental insights to the clinic
Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,019
Self-citationThe immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
The Intima: Soil for Atherosclerosis and Restenosis
Schwartz, S. M., deBlois, D., & O’Brien, E. R. M. (1995) · Circulation Research · doi:10.1161/01.res.77.3.445 · Cited by 971
Single-cell immune landscape of human atherosclerotic plaques
Fernandez, D. M., Rahman, A. H., Fernandez, N. F., Chudnovskiy, A., Amir, E.-A. D., Amadori, L., Khan, N. S., Wong, C. K., Shamailova, R., Hill, C. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0590-4 · Cited by 970 · cited 1×
“cyTOF have revealed a much greater heterogeneity than generally acknowledged and appreciated in the past.(128,129) The application of these”
BackgroundJernberg, T., Hasvold, P., Henriksson, M., Hjelm, H., Thuresson, M., & Janzon, M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu505 · Cited by 875 · cited 1×
“recurrent acute coronary syndromes can occur in a fifth of individuals despite optimum standard of care therapy in the first year.(114) While we”
BackgroundNobuyoshi, M., Kimura, T., Nosaka, H., Mioka, S., Ueno, K., Yokoi, H., Hamasaki, N., Horiuchi, H., & Ohishi, H. (1988) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(88)80046-9 · Cited by 875
Thrombosis: tangled up in NETs
Martinod, K., & Wagner, D. D. (2014) · Blood · doi:10.1182/blood-2013-10-463646 · Cited by 866
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation
Lewis, H. D., Liddle, J., Coote, J. E., Atkinson, S. J., Barker, M. D., Bax, B. D., Bicker, K. L., Bingham, R. P., Campbell, M., Chen, Y. H., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1735 · Cited by 779
Ridker, P. M., Devalaraja, M., Baeres, F. M. M., Engelmann, M. D. M., Hovingh, G. K., Ivkovic, M., Lo, L., Kling, D., Pergola, P., Raj, D., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00520-1 · Cited by 737
Self-citationAikawa, E., Nahrendorf, M., Figueiredo, J.-L., Swirski, F. K., Shtatland, T., Kohler, R. H., Jaffer, F. A., Aikawa, M., & Weissleder, R. (2007) · Circulation · doi:10.1161/circulationaha.107.732867 · Cited by 698
Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013) · Circulation · doi:10.1161/circulationaha.113.003008 · Cited by 692
Li, H., Cybulsky, M. I., Gimbrone, M. A., & Libby, P. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.197 · Cited by 689
Self-citationGalis, Z. S., Muszynski, M., Sukhova, G. K., Simon-Morrissey, E., Unemori, E. N., Lark, M. W., Amento, E., & Libby, P. (1994) · Circulation Research · doi:10.1161/01.res.75.1.181 · Cited by 646
Self-citationInterleukin-1 Beta as a Target for Atherosclerosis Therapy
Libby, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.028 · Cited by 619
Self-citationAmento, E. P., Ehsani, N., Palmer, H., & Libby, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1223 · Cited by 609
Self-citationEndothelial fluid shear stress sensing in vascular health and disease
Baeyens, N., Bandyopadhyay, C., Coon, B. G., Yun, S., & Schwartz, M. A. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83083 · Cited by 575
Impact of Statins on Serial Coronary Calcification During Atheroma Progression and Regression
Puri, R., Nicholls, S. J., Shao, M., Kataoka, Y., Uno, K., Kapadia, S. R., Tuzcu, E. M., & Nissen, S. E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.036 · Cited by 571
Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis
Döring, Y., Soehnlein, O., & Weber, C. (2017) · Circulation Research · doi:10.1161/circresaha.116.309692 · Cited by 571
Inflammation, Immunity, and Infection in Atherothrombosis
Libby, P., Loscalzo, J., Ridker, P. M., Farkouh, M. E., Hsue, P. Y., Fuster, V., Hasan, A. A., & Amar, S. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.1043 · Cited by 548
Self-citationWeight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women
Tchernof, A., Nolan, A., Sites, C. K., Ades, P. A., & Poehlman, E. T. (2002) · Circulation · doi:10.1161/hc0502.103331 · Cited by 541
Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice
Que, X., Hung, M.-Y., Yeang, C., Gonen, A., Prohaska, T. A., Sun, X., Diehl, C., Määttä, A., Gaddis, D. E., Bowden, K., et al. (2018) · Nature · doi:10.1038/s41586-018-0198-8 · Cited by 529 · cited 1×
“Oxidized LDL elicits a myriad of proatherogenic and pro-inflammatory functions of cells involved in atherogenesis, and can promote atherosclerosis in mice.(8) Despite this abundant and convincing body of experimental work and human observations, numerous strategies for combatting oxidative stress in human arteries hav…”
BackgroundInflammation and its Resolution as Determinants of Acute Coronary Syndromes
Libby, P., Tabas, I., Fredman, G., & Fisher, E. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.302699 · Cited by 521
Self-citationLibby, P., Pasterkamp, G., Crea, F., & Jang, I.-K. (2019) · Circulation Research · doi:10.1161/circresaha.118.311098 · Cited by 509
Self-citationMach, F., Schönbeck, U., Bonnefoy, J.-Y., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493
Self-citationEndothelial responses to shear stress in atherosclerosis: a novel role for developmental genes
Souilhol, C., Serbanovic-Canic, J., Fragiadaki, M., Chico, T. J., Ridger, V., Roddie, H., & Evans, P. C. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0239-5 · Cited by 480
Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction
Arbustini, E., Dal Bello, B., Morbini, P., Burke, A. P., Bocciarelli, M., Specchia, G., & Virmani, R. (1999) · Heart · doi:10.1136/hrt.82.3.269 · Cited by 477
Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment
Crea, F., & Libby, P. (2017) · Circulation · doi:10.1161/circulationaha.117.029870 · Cited by 476
Self-citationThe AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
Fidler, T. P., Xue, C., Yalcinkaya, M., Hardaway, B., Abramowicz, S., Xiao, T., Liu, W., Thomas, D. G., Hajebrahimi, M. A., Pircher, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03341-5 · Cited by 474
Self-citationErratum: Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.149 · Cited by 465
Mechanisms of progression in native coronary artery disease: role of healed plaque disruption
Mann, J., & Davies, M. J. (1999) · Heart · doi:10.1136/hrt.82.3.265 · Cited by 430
Mason, J. C., & Libby, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu403 · Cited by 420
Self-citationSugiyama, S., Kugiyama, K., Aikawa, M., Nakamura, S., Ogawa, H., & Libby, P. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000131784.50633.4f · Cited by 414
Self-citationSGalis, Z., MMuszynski, KSukhova, G., ESimon-Morrissey, NUnemori, E., WLark, M., EAmento, & PLibby (1994) · Circulation Research · Cited by 402
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
Jaiswal, S., & Libby, P. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0247-5 · Cited by 386 · cited 1×
“Individuals who harbour these mutant clones, however, have a much higher risk of cardiovascular disease than of developing acute leukaemia.(73,74) A num-”
BackgroundSelf-citationQuillard, T., Araújo, H. A., Franck, G., Shvartz, E., Sukhova, G., & Libby, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv044 · Cited by 380
Self-citationAtherosclerotic Plaque Healing
Vergallo, R., & Crea, F. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2000317 · Cited by 379
Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas
Zernecke, A., Winkels, H., Cochain, C., Williams, J. W., Wolf, D., Soehnlein, O., Robbins, C. S., Monaco, C., Park, I., McNamara, C. A., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316903 · Cited by 378
Role of immune cells in the removal of deleterious senescent cells
Kale, A., Sharma, A., Stolzing, A., Desprez, P.-Y., & Campisi, J. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00187-9 · Cited by 351
Folco, E. J., Mawson, T. L., Vromman, A., Bernardes-Souza, B., Franck, G., Persson, O., Nakamura, M., Newton, G., Luscinskas, F. W., & Libby, P. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311150 · Cited by 341
Self-citationLeukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease
Libby, P., Nahrendorf, M., & Swirski, F. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.048 · Cited by 324
Self-citationInflammation in Atherosclerosis—No Longer a Theory
Libby, P. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvaa275 · Cited by 314
Self-citationFranck, G., Mawson, T. L., Folco, E. J., Molinaro, R., Ruvkun, V., Engelbertsen, D., Liu, X., Tesmenitsky, Y., Shvartz, E., Sukhova, G. K., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312494 · Cited by 304
Self-citationMechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
Yurdagul, A., Doran, A. C., Cai, B., Fredman, G., & Tabas, I. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00086 · Cited by 300 · cited 1×
“The clearance of dead and dying cells, a process known as efferocytosis, can limit the size of the necrotic core according to mouse experiments.(62) Defective clearance of dead cells can favour the expansion of the plaque’s necrotic or lipid core.”
BackgroundThe role of B cells in atherosclerosis
Sage, A. P., Tsiantoulas, D., Binder, C. J., & Mallat, Z. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0106-9 · Cited by 298
Requiem for the ‘vulnerable plaque’
Libby, P., & Pasterkamp, G. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv349 · Cited by 295
Self-citationFrom Focal Lipid Storage to Systemic Inflammation
Libby, P., & Hansson, G. K. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.061 · Cited by 288
Self-citationGALIS, Z. S., MUSZYNSKI, M., SUKHOVA, G. K., SIMON‐MORRISSEY, E., & LIBBY, P. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17348.x · Cited by 274
Self-citationIL-17 and Th17 Cells in Atherosclerosis: Subtle and Contextual Roles
Taleb, S., Tedgui, A., & Mallat, Z. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303567 · Cited by 260
Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy
Pradhan, A. D., Aday, A. W., Rose, L. M., & Ridker, P. M. (2018) · Circulation · doi:10.1161/circulationaha.118.034645 · Cited by 258 · cited 1×
“take satisfaction in our current armamentarium for combatting atherosclerosis, much remains undone.(115) The introduction of newer therapies”
BackgroundTargeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
Sager, H. B., Heidt, T., Hulsmans, M., Dutta, P., Courties, G., Sebas, M., Wojtkiewicz, G. R., Tricot, B., Iwamoto, Y., Sun, Y., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016160 · Cited by 253
Self-citationFerrante, G., Nakano, M., Prati, F., Niccoli, G., Mallus, M. T., Ramazzotti, V., Montone, R. A., Kolodgie, F. D., Virmani, R., & Crea, F. (2010) · Circulation · doi:10.1161/circulationaha.110.955302 · Cited by 235
Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
Viola, J. R., Lemnitzer, P., Jansen, Y., Csaba, G., Winter, C., Neideck, C., Silvestre-Roig, C., Dittmar, G., Döring, Y., Drechsler, M., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309492 · Cited by 226 · cited 1×
“Boosting pro-resolving mediators could mitigate atherosclerosis with less liability for impaired host defences.(59) As noted above, cell death opposes proliferation of both smooth muscle cells and mononuclear phagocytes.”
BackgroundUnstable Angina: Is It Time for a Requiem?
Braunwald, E., & Morrow, D. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001258 · Cited by 226 · cited 1×
“The categorization unstable angina has undergone reevaluation in the current era and is near extinction.[83] With”
BackgroundNeutrophil Elastase in Human Atherosclerotic Plaques: Production by Macrophages
Dollery, C. M., Owen, C. A., Sukhova, G. K., Krettek, A., Shapiro, S. D., & Libby, P. (2003) · Circulation · doi:10.1161/01.cir.0000072792.65250.4a · Cited by 225
Self-citationColchicine in Patients with Chronic Coronary Disease
(2021) · New England Journal of Medicine · doi:10.1056/nejmc2034992 · Cited by 217
Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials
Liu, C.-L., Guo, J., Zhang, X., Sukhova, G. K., Libby, P., & Shi, G.-P. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0002-3 · Cited by 210
Self-citationPartida, R. A., Libby, P., Crea, F., & Jang, I.-K. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx786 · Cited by 204
Self-citationMonoclonality of smooth muscle cells in human atherosclerosis.
Murry, C. E., Gipaya, C. T., Bartosek, T., Benditt, E. P., & Schwartz, S. M. (1997) · Europe PMC (PubMed Central) · Cited by 192
Apolipoprotein C-III: from pathophysiology to pharmacology
Norata, G. D., Tsimikas, S., Pirillo, A., & Catapano, A. L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.07.001 · Cited by 182
High dose and long-term statin therapy accelerate coronary artery calcification
Henein, M., Granåsen, G., Wiklund, U., Schmermund, A., Guerci, A., Erbel, R., & Raggi, P. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.072 · Cited by 181
Boosting Inflammation Resolution in Atherosclerosis
Fredman, G., & Tabas, I. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.01.018 · Cited by 174
Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery
Rogers, M. A., & Aikawa, E. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0123-8 · Cited by 174
Mayerl, C., Lukasser, M., Sedivy, R., Niederegger, H., Seiler, R., & Wick, G. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0176-7 · Cited by 173
Puri, R., Libby, P., Nissen, S. E., Wolski, K., Ballantyne, C. M., Barter, P. J., Chapman, M. J., Erbel, R., Raichlen, J. S., Uno, K., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jet251 · Cited by 173
Self-citationTemporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease
Pasterkamp, G., den Ruijter, H. M., & Libby, P. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.166 · Cited by 168
Self-citationMechanisms of erosion of atherosclerotic plaques
Quillard, T., Franck, G., Mawson, T., Folco, E., & Libby, P. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000440 · Cited by 168
Self-citationLibby, P. (2021) · Cells · doi:10.3390/cells10040951 · Cited by 167
Self-citationHealed Culprit Plaques in Patients With Acute Coronary Syndromes
Fracassi, F., Crea, F., Sugiyama, T., Yamamoto, E., Uemura, S., Vergallo, R., Porto, I., Lee, H., Fujimoto, J. G., Fuster, V., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.093 · Cited by 165
MR Imaging of Carotid Plaque Composition During Lipid-Lowering Therapy
Zhao, X.-Q., Dong, L., Hatsukami, T., Phan, B. A., Chu, B., Moore, A., Lane, T., Neradilek, M. B., Polissar, N., Monick, D., et al. (2011) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2011.06.013 · Cited by 161
Nakashima, Y., Chen, Y.-X., Kinukawa, N., & Sueishi, K. (2002) · Virchows Archiv · doi:10.1007/s00428-002-0605-1 · Cited by 160
Targeting the Immune System in Atherosclerosis
Zhao, T. X., & Mallat, Z. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.083 · Cited by 158
Clancy, D. M., Henry, C. M., Sullivan, G. P., & Martin, S. J. (2017) · FEBS Journal · doi:10.1111/febs.14075 · Cited by 151
Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults
Miedema, M. D., Dardari, Z. A., Nasir, K., Blankstein, R., Knickelbine, T., Oberembt, S., Shaw, L., Rumberger, J., Michos, E. D., Rozanski, A., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.7440 · Cited by 146
Aragam, K. G., & Natarajan, P. (2020) · Circulation Research · doi:10.1161/circresaha.120.315928 · Cited by 146
Bruschke, A. V. G., Kramer, J. R., Bal, E. T., Haque, I. U., Detrano, R., & Goormastic, M. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90772-2 · Cited by 141
Effects of aging and lifelong aerobic exercise on basal and exercise-induced inflammation
Lavin, K. M., Perkins, R. K., Jemiolo, B., Raue, U., Trappe, S. W., & Trappe, T. A. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00495.2019 · Cited by 134
Wang, Y., Nanda, V., DiRenzo, D. M., Ye, J., Xiao, S., Kojima, Y., Howe, K. L., Jarr, K.-U., Flores, A. M., Tsantilas, P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006348117 · Cited by 132
Molinaro, R., Yu, M., Sausen, G., Bichsel, C. A., Corbo, C., Folco, E. J. E., Lee, G. Y., Liu, Y., Tesmenitsky, Y., Shvartz, E., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab074 · Cited by 130
Self-citationWesseling, M., Sakkers, T. R., de Jager, S. C. A., Pasterkamp, G., & Goumans, M. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.02.006 · Cited by 129
Vergallo, R., Porto, I., D’Amario, D., Annibali, G., Galli, M., Benenati, S., Bendandi, F., Migliaro, S., Fracassi, F., Aurigemma, C., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0275 · Cited by 128
Hansen, S. E. J., Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.294926 · Cited by 121
Regulatory T‐cell immunity and its relevance to atherosclerosis
Taleb, S., Tedgui, A., & Mallat, Z. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01944.x · Cited by 119
Never waste a good crisis: confronting reproducibility in translational research
Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.006 · Cited by 117 · cited 1×
“We also must strive to avoid glib extrapolations of animal data to human atherosclerosis.(130,131) We previously highlighted a tendency to gloss”
BackgroundTargeting B Cells in Atherosclerosis: Closing the Gap From Bench to Bedside
Tsiantoulas, D., Sage, A. P., Mallat, Z., & Binder, C. J. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303569 · Cited by 117
Leistner, D. M., Kränkel, N., Meteva, D., Abdelwahed, Y. S., Seppelt, C., Stähli, B. E., Rai, H., Skurk, C., Lauten, A., Mochmann, H., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa703 · Cited by 116
Self-citationImplications of the Monoclonal Character of Human Atherosclerotic Plaques
Benditt, E. P. (1976) · Beiträge zur Pathologie · doi:10.1016/s0005-8165(76)80137-0 · Cited by 112
Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity
Schloss, M. J., Swirski, F. K., & Nahrendorf, M. (2020) · Circulation Research · doi:10.1161/circresaha.120.315936 · Cited by 106
Gisterå, A., Klement, M. L., Polyzos, K. A., Mailer, R. K., Duhlin, A., Karlsson, M. C. I., Ketelhuth, D. F. J., & Hansson, G. K. (2018) · Circulation · doi:10.1161/circulationaha.118.034076 · Cited by 82
Fat Fuels the Flame: Triglyceride-Rich Lipoproteins and Arterial Inflammation
Libby, P. (2007) · Circulation Research · doi:10.1161/01.res.0000259393.89870.58 · Cited by 81
Self-citationEvidence for a Monoclonal Origin of Human Atherosclerotic Plaques and Some Implications
Benditt, E. P. (1974) · Circulation · doi:10.1161/01.cir.50.4.650 · Cited by 77
Apolipoprotein C-III: Going Back to the Future for a Lipid Drug Target
Huff, M. W., & Hegele, R. A. (2013) · Circulation Research · doi:10.1161/circresaha.113.301464 · Cited by 70
Revealing the Origins of Foam Cells in Atherosclerotic Lesions
Owsiany, K. M., Alencar, G. F., & Owens, G. K. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312557 · Cited by 67
Dynamic Nature of Nonculprit Coronary Artery Lesion Morphology in STEMI
Zhao, Z., Witzenbichler, B., Mintz, G. S., Jaster, M., Choi, S., Wu, X., He, Y., Margolis, M. P., Dressler, O., Cristea, E., et al. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.08.010 · Cited by 63
IMPLICATIONS OF THE MONOCLONAL CHARACTER OF HUMAN ATHEROSCLEROTIC PLAQUES*
Benditt, E. P. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb43342.x · Cited by 63
Murine "model" monotheism: an iconoclast at the altar of mouse
Libby, P. (2015) · Circulation Research · doi:10.1161/circresaha.115.307523 · Cited by 60
Self-citationPuri, R., Nissen, S. E., Shao, M., Ballantyne, C. M., Barter, P. J., Chapman, M. J., Erbel, R. M., Libby, P., Raichlen, J. S., Uno, K., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303932 · Cited by 58
Self-citationHelmke, A., Casper, J., Nordlohne, J., David, S., Haller, H. G., Zeisberg, E. M., & von Vietinghoff, S. (2018) · The FASEB Journal · doi:10.1096/fj.201801238r · Cited by 58
New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes
Kolte, D. S., Libby, P., & Jang, I. (2021) · JAMA · doi:10.1001/jama.2021.0069 · Cited by 50
Self-citationBraunwald, E. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.01.003 · Cited by 40
Proteinases and plaque rupture: unblocking the road to translation
Newby, A. C. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000111 · Cited by 40
Effects of aging and lifelong aerobic exercise on basal and exercise-induced inflammation in women
Lavin, K. M., Perkins, R. K., Jemiolo, B., Raue, U., Trappe, S. W., & Trappe, T. A. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00655.2020 · Cited by 34
Diagnosis and Management of STEMI Arising From Plaque Erosion
Holmes, D. R., Lerman, A., Moreno, P., King, S. B., & Sharma, S. K. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2013.01.005 · Cited by 26
Assisted Living in the Atheroma: Elderly Macrophages Promote Plaques
Libby, P. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.11.013 · Cited by 18
Self-citation
Cited by
The Role of Inflammation in Cardiovascular Disease
Henein, M. Y., Vancheri, S., Longo, G., & Vancheri, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112906 · Cited by 724
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 349
Expanding biology of PCSK9: roles in atherosclerosis and beyond
Seidah, N. G., & Garçon, D. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01057-z · Cited by 76
Lecis, D., Prandi, F. R., Barone, L., Belli, M., Sergi, D., Longo, S., Muscoli, S., Romeo, F., Federici, M., Lerakis, S., et al. (2023) · Biomolecules · doi:10.3390/biom13121695 · Cited by 23
“Oral semaglutide approved by the FDA in 2019 is coformulated with sodium N-[8-(2-hydroxybenzoyl) aminocaprylate] (SNAC).”
Ren, P., Zheng, C., Pang, Y., Qiang, Y., Sun, S., Wang, Q., Xu, W., Lee, M., Lu, Z., Zhou, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01011-z · Cited by 6
Metadata
- Authors
- Libby, P.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-09-22
- Volume
- 117
- Issue
- 13
- Pages
- 2525-2536
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W3201330294
- Cited by
- 414
- References
- 132
- FWCI
- 18.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.